News

Clinical Trials Arena5h
FDA clears OBI Pharma’s IND to begin Phase I/II solid tumour trial
OBI Pharma has received clearance from the US FDA for an IND application for OBI-902 to begin a Phase I/II trial for advanced ...
Clinical Trials Arena10h
Chengdu Origen and Vanotech dose first subject in gene therapy trial for wet AMD
Chengdu Origen and Vanotech have initiated the first subject dosing in the Phase I trial, VAN-2401, of KH658 for treating wet ...